Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 25INDUSTRY 10NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 35Prostatic Neoplasms 26Carcinoma, Non-Small-Cell Lung 24Lung Neoplasms 15Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Carcinoma, Ovarian Epithelial 7Adenocarcinoma of Lung 7Inflammatory Breast Neoplasms 6Fallopian Tube Neoplasms 6Breast Neoplasms, Male 6Stomach Neoplasms 4Head and Neck Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Tongue Neoplasms 3Pain 3Neoplasm Metastasis 3Adenocarcinoma, Bronchiolo-Alveolar 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Pleural Effusion, Malignant 2Oropharyngeal Neoplasms 2Neoplasms 2Lymphoid Interstitial Pneumonia 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma 2Brenner Tumor 2

Interventions

Specimen Handling 17Magnetic Resonance Spectroscopy 15Gemcitabine 13Cisplatin 8Biopsy 8Radiotherapy 7Mitomycin 6Cystoscopy 6pembrolizumab 5Trastuzumab 5Paclitaxel 5Fluorouracil 5cabozantinib 4atezolizumab 4Radiation 4erdafitinib 3dehydroftorafur 3Transurethral Resection of Bladder 3Sunitinib 3Sorafenib 3Platinum 3Nivolumab 3Mitozytrex 3Gene Expression Profiling 3Fluorodeoxyglucose F18 3Carboplatin 31,2-diaminocyclohexaneplatinum II citrate 3valrubicin 2tipifarnib 2sapanisertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Urinary Bladder Neoplasms × Docetaxel × Clear all
NCT04579224 2026-05-13

Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
184 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00005958 2013-12-04

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡